Anzeige
Mehr »
Dienstag, 07.10.2025 - Börsentäglich über 12.000 News
Golden Cross könnte Australiens nächste Goldentdeckung in der Pipeline haben!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40VM0 | ISIN: US8902608392 | Ticker-Symbol: TPM0
Tradegate
07.10.25 | 17:06
19,600 Euro
-5,77 % -1,200
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
TONIX PHARMACEUTICALS HOLDING CORP Chart 1 Jahr
5-Tage-Chart
TONIX PHARMACEUTICALS HOLDING CORP 5-Tage-Chart
RealtimeGeldBriefZeit
19,50019,70017:14
19,50019,70017:14

Aktuelle News zur TONIX PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15:06Tonix to advance cyclobenzaprine into phase 2 for depression2
TONIX PHARMACEUTICALS Aktie jetzt für 0€ handeln
14:31Tonix Pharmaceuticals Holding Corp. - 8-K, Current Report3
30.09.Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kamath as Head of Market Access238Mr. Kamath brings more than 25 years of market access, pricing, and commercial operations experience to Tonix On August 15, 2025, the U.S. Food and Drug Administration approved Tonmya (cyclobenzaprine...
► Artikel lesen
29.09.Tonix Pharmaceuticals Holding Corp. - 8-K, Current Report3
29.09.Tonix Pharmaceuticals To Begin Phase 2 Study Of TNX-2900 For Prader-Willi Syndrome In 20261
29.09.Tonix to begin phase 2 trial of PWS treatment with orphan status2
29.09.Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Plans to Initiate Prader-Willi Syndrome Phase 2 Trial of TNX-2900 (Intranasal Potentiated Oxytocin) in 2026220Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with Prader-Willi Syndrome under a cleared IND TNX-2900...
► Artikel lesen
18.09.Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Positive Pre-IND Meeting with FDA for TNX-102 SL for the Treatment of Major Depressive Disorder217Tonix anticipates filing the IND application in the fourth quarter of 2025 TNX-102 SL is a potential first-in-class treatment for targeting the disturbed sleep associated with depression TNX-102 SL...
► Artikel lesen
17.09.Tonix Pharmaceuticals gets global rights to Lyme disease treatment15
17.09.Tonix In-Licenses TNX-4800 For Seasonal Lyme Disease Prevention-
17.09.Tonix sichert sich Lizenz für monoklonalen Antikörper zur Prävention von Lyme-Borreliose9
17.09.Tonix licenses monoclonal antibody for Lyme disease prevention3
17.09.Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Seasonal Prevention of Lyme Disease (TNX-4800)130Positive Phase 1 study showed safety, tolerability and a linear pharmacokinetic: pharmacodynamic: efficacy relationship (1: 1: 1) Planning adaptive Phase 2/3 study Approximately 70 million people...
► Artikel lesen
17.09.Tonix Pharmaceuticals Holding Corp. - 8-K, Current Report7
20.08.SA analyst upgrades/downgrades: HD, AAPL, TMUS, TNXP41
18.08.Tonix drops 20% despite winning approval for fibromyalgia drug56
18.08.Tonix Pharma's Drug Gets FDA Nod For Chronic Pain Condition, First New Therapy In Over 15 Years27
18.08.FDA Approves New Fibromyalgia Drug, Tonix Shares Climb16
18.08.Stocks Moving Premarket: Propanc Biopharma, BTAI, Tonix Pharmaceuticals, Dayforce, TPI Composites, And Other Gainers & Losers599OTTAWA (dpa-AFX) - At 6.50 a.m. ET on Monday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening...
► Artikel lesen
18.08.Tonix ends 16-year hiatus in fibromyalgia treatment11
Weiter >>
88 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1